Questions about cancer? Freephone 1800 200 700 Irish Cancer Society Nurseline

About this trial

The purpose of this study is to investigate if two medications; Rucaparib and Nivolumab used together or separately are better than the current best available treatment for patients who have had platinum-based chemotherapy for ovarian cancer.

Patient Profile

Ovarian cancer

Where’s this trial being run?

Bon Secours Cork, Cork University Hospital, St James’s Hospital, University Hospital Limerick, and University Hospital Waterford

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: Athena
Number: CTRIAL-IE 18-26
Full Title:

ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Nivolumab and Rucaparib Combination Switch Maintenance following Front-Line Platinum-based Chemotherapy in Ovarian Cancer Patients)

Principal Investigator: Dr Dearbhaile Collins (Cork University Hospital)
Type: Collaborative
Sponsor:

Clovis Oncology, Inc.

Recruitment Started: Global: May 2018
Ireland: February 2019
Global Recruitment Target: 1012
Ireland Recruitment Target: 20 patients over 12 months